ROBERT J. MICHEL - Corporate Board Profile

BIO KEY INTERNATIONAL INC

Filing Date	Source Excerpt
2018-04-30	Robert J. Michel, 61,has served as a Director of the Company since April 10, 2017.
2019-04-30	Robert J. Michel, 62, has served as a Director of the Company since April 10, 2017. He has over 30 years of accounting and financial management experience. Our audit committee is comprised of Robert J. Michel (Chair), Fabian Shin and Pieter Knook. Our compensation committee is comprised of Thomas Bush, III (Chair) and Robert Michel.
2020-06-15	Robert J. Michel, 63, has served as a Director of the Company since April 10, 2017. ... Our audit committee is comprised of Robert J. Michel (Chair), Fabian Shin and Pieter Knook... Our compensation committee is comprised of Thomas Bush, III (Chair) and Robert Michel.
2021-05-04	Robert J. Michel, 64, has served as a Director of the Company since April 10, 2017. He has over 30 years of accounting and financial management experience. Since September, 2018, he has served as the Chief Financial Officer of Daxor Corporation (NYSE MKT: DXR), a medical device manufacturing company specializing in blood volume analysis. Prior to Daxor, from November, 2017 until September 2018, Mr. Michel served as the CFO of Roadway Moving, Inc., a transportation, moving and storage company located in New York City. Immediately prior to Roadway Moving, Inc., Mr. Michel served as a consultant with Feuer & Orlando, LLP, a New York City based CPA firm, from May, 2016 until November 2017. From 2009 until March, 2016, Mr. Michel was the Chief Financial Officer of Asta Funding, Inc. (Nasdaq: ASFI), a diversified financial services company where he was responsible for all financial matters and SEC reporting. From 2004 until 2009, Mr. Michel served as the Controller and the Director of Financial Reporting and Compliance for Asta Funding. Mr. Michel is a certified public accountant, earned a MBA in Taxation from St. John’s University, and a BS in Business Administration from Villanova University. Mr. Michel gained his public accounting experience at PricewaterhouseCoopers in New York. We believe Mr. Michel’s qualifications to sit on the board of directors include his substantial experience in accounting and financial management for public companies which provide the board with a deep knowledge of financial and SEC reporting and strengthen the board’s collective qualifications, skills, and experience.
2022-05-05	Robert J. Michel, 65, has served as a Director of the Company since April 10, 2017. ... Our audit committee is comprised of Robert J. Michel (Chair), Pieter Knook, and Emmanuel Alia, all of whom meet the independence standards for purposes of serving on an audit committee established by Nasdaq and under the Exchange Act.
2023-06-09	Robert J. Michel, 66, has served as a Director of the Company since April 10, 2017. He has over 30 years of accounting and financial management experience. Since September, 2018, he has served as the Chief Financial Officer of Daxor Corporation (Nasdaq: DXR), a medical device manufacturing company specializing in blood volume analysis. Prior to Daxor, from November, 2017 until September 2018, Mr. Michel served as the CFO of Roadway Moving, Inc., a transportation, moving and storage company located in New York City. Mr. Michel spent 15 years at Asta Funding, Inc. (Nasdaq: ASFI), a diversified financial services company, including serving as its Chief Financial Officer from 2009 until 2017 where he was responsible for all financial matters and SEC reporting. Mr. Michel is a certified public accountant, earned an MBA in Taxation from St. John’s University, and a BS in Business Administration from Villanova University.
2023-11-24	Robert J. Michel
2024-07-10	Robert J. Michel, 67, has served as a Director of the Company since April 10, 2017. He has over 30 years of accounting and financial management experience. Mr. Michel is a certified public accountant. Our audit committee is comprised of Cameron Williams (Chair), Robert Michel, and Emmanuel Alia. The compensation committee is comprised of Cameron Williams (Chair) and Robert Michel. At December 31, 2023, Mr. Michel held options to purchase 117 shares of common stock and held 278 shares of restricted common stock. Director compensation table shows Robert J. Michel received $11,002 in stock awards in 2023.